| The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers L Han, L Diao, S Yu, X Xu, J Li, R Zhang, Y Yang, HMJ Werner, ... Cancer cell 28 (4), 515-528, 2015 | 473 | 2015 |
| Functional annotation of rare gene aberration drivers of pancreatic cancer YH Tsang, T Dogruluk, PM Tedeschi, J Wardwell-Ozgo, H Lu, M Espitia, ... Nature communications 7 (1), 10500, 2016 | 63 | 2016 |
| Development and analytical validation of a 523-gene clinical assay for cell-free DNA. R Harrington, B Das, T Jiang, JS LoCoco, R Patidar, A Peach, C Zhao, ... Journal of Clinical Oncology 37 (15_suppl), 3039-3039, 2019 | 1 | 2019 |
| Genomic landscape and stability of preclinical models in NCI's patient-derived models repository TC Chang, B Das, L Chen, PIF Wu, YA Evrard, R Pauly, DL Newton, ... Cancer Research 84 (6_Supplement), 6914-6914, 2024 | | 2024 |
| A Concordance Study of NGS Laboratories in the NCI ComboMATCH-Designated Laboratory Network S Narava, C Karlovich, J Li, L Chen, N Nair, B Das, B Kim, L Yee, L Harris, ... JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S89-S89, 2023 | | 2023 |
| Comparative Analysis of Gene Fusion Detection Using Multiple Platforms: TruSeq RNA Exome, Total RNASeq, and Archer FUSIONPlex R Pauly, A Chapman, L Chen, B Das, J Doroshow, Y Evrard, ... JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S77-S78, 2023 | | 2023 |
| Chromosomal aneuploidy, whole-genome doubling and mutational signatures in NCI PDMR models L Chen, B Das, TC Chang, YA Evrard, CA Karlovich, A Chapman, ... Cancer Research 83 (7_Supplement), 6072-6072, 2023 | | 2023 |
| Molecular subclassification of NCI PDMR breast cancer models using PAM50 gene expression signature PI Wu, L Dutko, S Jiwani, L Chen, B Das, TC Chang, YA Evrard, ... Cancer Research 83 (7_Supplement), 2050-2050, 2023 | | 2023 |
| Developing a Robust Bioinformatics Pipeline for NCI Clinical Whole Exome Sequencing Assay L Chen, S Narava, N Nair, A Hayes, L Romero, A Chapman, R Thorton, ... JOURNAL OF MOLECULAR DIAGNOSTICS 24 (10), S78-S79, 2022 | | 2022 |
| Development and Analytical Performance of NCI Clinical Whole-Exome Sequencing (NcWES) Assay to Support NCI Precision Medicine Clinical Trials N Nair, L Chen, S Narava, A Hayes, L Romero, A Chapman, R Thorton, ... JOURNAL OF MOLECULAR DIAGNOSTICS 24 (10), S99-S100, 2022 | | 2022 |
| Quality control workflows developed for the NCI Patient-Derived Models Repository using low pass whole genome sequencing and whole exome sequencing TC Chang, L Chen, B Das, YA Evrard, CA Karlovich, T Vilimas, ... Cancer Research 82 (12), 2022 | | 2022 |
| Genomic characterization of PDX models from rare cancer patients in the NCI Patient-Derived Models Repository L Chen, R Pauly, TC Chang, B Das, YA Evrard, CA Karlovich, T Vilimas, ... Cancer Research 82 (12), 2022 | | 2022 |
| Study of tumor heterogeneity and subclonality in primary pancreatic and metastatic sites from rapid autopsy patients in PDMR L Chen, B Das, YA Evrard, CA Karlovich, T Vilimas, A Peach, C Alyssa, ... Cancer Research 81 (13_Supplement), 3139-3139, 2021 | | 2021 |
| Patient-derived organoid and cell culture models from the NCI Patient-Derived Models Repository (NCI PDMR) preserve genomic stability and heterogeneity of patient tumor specimens B Das, YA Evrard, L Chen, R Patidar, T Vilimas, JN McCutcheon, ... Cancer Research 80 (16_Supplement), 3916-3916, 2020 | | 2020 |
| Genomic landscape of acquired uniparental disomy in NCI PDMR patient derived xenograft models R Patidar, L Chen, CA Karlovich, B Das, YA Evrard, T Vilimas, ... Cancer Research 80 (16), 2020 | | 2020 |
| Genomic characterization of preclinical models derived from primary and metastatic sites from rapid autopsy patients in PDMR. L Chen, R Patidar, B Das, YA Evrard, CA Karlovich, T Vilimas, N Nair, ... Journal of Clinical Oncology 38 (15_suppl), e13506-e13506, 2020 | | 2020 |
| Development and analytical validation of a 523-gene assay for cell-free DNA R Harrington, B Das, T Jiang, JS LoCoco, R Patidar, A Peach, C Zhao, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 15, 105-105, 2019 | | 2019 |
| Integrative analyses of signaling and DNA damage repair pathways in patient-derived xenograft (PDX) models from NCI’s patient-derived models repository (PDMR). B Das, YA Evrard, L Chen, R Patidar, T Vilimas, JN McCutcheon, A Peach, ... Journal of Clinical Oncology 37 (15), 2019 | | 2019 |
| Abstract B106: Personalized functional screens for gene drivers of pancreatic cancer YH Tsang, T Dogruluk, H Lu, R Minelli, N Nair, MC Gingras, AK Eterovic, ... Cancer Research 75 (13_Supplement), B106-B106, 2015 | | 2015 |
| Abstract B131: A prioritization pipeline for functionally annotating oncogenic somatic driver aberrations in cancer. T Dogruluk, YH Tsang, N Nair, J Zhang, T Heffernan, L Chin, G Mills, ... Molecular Cancer Therapeutics 12 (11_Supplement), B131-B131, 2013 | | 2013 |
